Trademark: 90627260
Status Date
Monday, September 5, 2022
Filing Date
Tuesday, April 6, 2021
Published for Opposition
Tuesday, December 7, 2021
Abandoned Date
Monday, September 5, 2022
5 pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
Sep 6, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 5, 2022
Abandonment - No Use Statement Filed
Feb 1, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 7, 2021
Published For Opposition
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Nov 4, 2021
Approved For Pub - Principal Register
Oct 29, 2021
Assigned To Examiner
Jul 15, 2021
New Application Office Supplied Data Entered
Apr 9, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24